Drug ‐coated balloon: Long‐term outcome from a real world three‐center experience

ConclusionsDCB proved a valid revascularization strategy in an all‐comers population of patients with ISR and de novo lesions in small vessels, with an acceptable rate of cardiac events up to 48 months follow‐up.

Source: Journal of Interventional Cardiology - June 1, 2017 Category: Cardiology Authors: Carlo Zivelonghi, Matteo Ghione, Giovanni Benfari, Magdalena Cuman, Alfredo Fede, Mattia Lunardi, Stefano Cordone, Marco Botta, Andrea Pacchioni, Pietro Bellone, Bernhard Reimers, Flavio L. Ribichini Tags: ORIGINAL INVESTIGATION Source Type: research